An OTC Antiviral Drug Candidate for Children of 6+ Years Old
May 15, 2020
• Dimetapp Children's Cold & Allergy
(Two Active Ingredients: Brompheniramine-C16H19BrN2 and Phenylephrine-C9H13NO2)
Dietary Supplements & OTC Drugs as Antiviral Drug Candidates
The main target zones of a drug molecule are instructed in the round brackets.
•Pantethine (Alveolar walls & upper respiratory tract. A broad-spectrum agent)
• Glutamine (Alveolar walls. A broad-spectrum agent)
• Resveratrol (Oxygen-rich spots near alveoli & brain.) 
• Melatonin (Alveolar walls & blood. A broad-spectrum agent) [1-5]
•Vitamin B12 (Act as an immune defender responding to CD4)
• Nicotine Patch (Alveolar walls & liver. A broad-spectrum agent)
•Fexofenadine (Upper respiratory tract) [8-10]
•Quercetin (A family member of Favipiravir)[11-15]
•α-Cyclodextrin (Alveolar walls & blood vessels) New
 Victoria Yunez Behm, et al., "Personalized Nutrition & the COVID-19 Era", prepared by the Personalized Nutrition & COVID-19 Task Force of the American Nutrition Association, updated May 5, 2020.
 ClinicalTrials.gov Identifier: NCT04353128.
 Rui Zhang et al., "COVID-19: Melatonin as a potential adjuvant treatment", Life Sciences
, Vol. 250, 1 June 2020.
 George Anderson & Russel J. Reiter, "Melatonin: Roles in influenza, Covid‐19, and other viral infections", Reviews in Medical Virology
, 21 April 2020.
 Admin, "Dr. Neel a pioneer in treating COVID-19 patients with melatonin", The Devine News
, May 8, 2020.
 ClinicalTrials.gov Identifier: NCT04395768.
 "French scientists to test theory that nicotine combats COVID-19",
-Paris(Reuters), April 27, 2020.
 Mohammad Injamul Hoq, et al., "Is COVID-19 spreading and curing silently: an observation of three family clusters in Bangladesh", J Basic Clin Physiol Pharmacol
, 2020, 31(6).
 Takeshi Arashiro, et al, "COVID-19 in 2 Persons with Mild Upper Respiratory Tract Symptoms on a Cruise Ship, Japan"(Figure), Emerg Infect Dis.
, 2020, 26(6).
 Henry Ford Health System Staff, "Over-The-Counter Remedies To Ease COVID-19 Symptoms", Henry Ford Health System
, December 12, 2020
 Amr K. Ahmed, et al, "Effects of Quadruple Therapy: Zinc, Quercetin, Bromelain and Vitamin C on the Clinical Outcomes of Patients Infected with COVID-19", Rea Int J of End and
, August 29, 2020.
 "Supplements For COVID-19: Quercetin Emerging As An Adjuvant For COVID-19 Treatments", Thailand Medical News
, August 13, 2020.
 ClinicalTrials.gov Identifier: NCT04578158
 ClinicalTrials.gov Identifier: NCT04377789
 ClinicalTrials.gov Identifier: NCT04468139